| (HKD) | Dec 2019 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -221.24M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 2181.HK returned -44.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -14.0% |
| 1 year | -44.2% |
| 5 years | -54.3% |
| All-time high | $1.50 (Jun 2019) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in 2181.HK would be worth today ›No. Mabpharm Limited has not paid a dividend in the past 12 months.
Mabpharm Limited is part of the Healthcare sector.
Mabpharm Limited has a market cap of 1.77B HKD, based on the latest quote.
